Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06613412). This is a study registration, not published results. Lead sponsor: Guangzhou Medical University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 20 participants (ACTUAL). Conditions: Pulmonary Nodule. Interventions: DIAGNOSTIC_TEST: Remote Robotic Bronchoscopy system. Primary outcome measures: equipment failure rate , During the bronchoscopy. Brief summary: Robotic bronchoscopy represents the latest localization technology for peripheral pulmonary nodules, enabling precise and stable manipulation and potentially improving the diagnostic yield of peripheral lung pathologies. Its safety and feasibility have been validated in previous studies. Nonetheless, disparities in interventional equipment and technical expertise remain important contributors to regional variation in the diagnostic performance of peripheral lung lesion biopsy, particularly in remote or underdeveloped areas. The advancement of fifth-generation (5G) network technology has promoted the development of telemedicine by enabling remote operation, real-time communication, and multi-site collaboration. Integration of 5G communication with robotic bronchoscopy may therefore provide a new approach to extend advanced bronchoscopic expertise across geographically separated medical centers. This prospective, multicenter clinical study will include 20 patients with peripheral pulmonary nodules or lesions requiring bronchoscopic localization and sampling. Ten patients will undergo 5G-assisted remote robotic bronchoscopy (remote group), and 10 patients will undergo conventional locally operated robotic bronchoscopy using the same robotic bronchoscopy platform (local group). The study will evaluate the safety and efficacy of remote robotic bronchoscopy and explore its procedural and diagnostic performance in comparison with local robotic bronchoscopy.